Tag: Christopher Porter
Seaport Therapeutics secures $100M to harness Monash invention
Seaport Therapeutics, a biopharmaceutical company in the clinical stage, centred on an innovative drug delivery system initially created by researchers from Monash University, announced the completion of a Series A funding round, which raised USD 100 million (AUD 154 million).
Featured Article
Good Design Australia opens entries for 2026 awards
For more than six decades, Good Design Australia has celebrated the power of design to shape innovation, industry, and everyday life. Its flagship program, the Australian Good Design Awards, recognises projects that show how thoughtful design can enhance products, services, systems, and communities.
